Exact Mass: 426.010086
Exact Mass Matches: 426.010086
Found 68 metabolites which its exact mass value is equals to given mass value 426.010086,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Axillarin 7-sulfate
C17H14O11S (426.02568140000005)
Eupatolitin 3-O-sulfate
C17H14O11S (426.02568140000005)
3-[3,5-bis(trifluoromethyl)anilino]-2-(2-thienylsulfonyl)acrylonitrile
C15H8F6N2O2S2 (425.99313799999993)
Methyl 2, 7-dichloronorpsoromate|methyl 2,7-dichloronorpsoromate
2-(3,4-Dihydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-5,7-dihydroxy-2,3-epoxy-3,4-dihydro-2H-1-benzopyran-4-one
C21H14O10 (426.05869440000004)
ethyl (3,5-dibromo-4,4-diethoxy-1-hydroxycyclohexa-2,5-dien-1-yl)acetate
THIOPHOSPHORYL-PMMH-3 DENDRIMER, GENERATION 0.5
C21H15O6PS (426.03269400000005)
3-Nitro-N-(5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)benzamide
Methyl 8-phenoxy-4-{[(trifluoromethyl)sulfonyl]oxy}-2-naphthoate
C19H13F3O6S (426.03849140000005)
5-chloro-2-[[1-(2-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]benzenesulphonic acid
C16H12Cl2N4O4S (425.99562920000005)
Calcium ascorbate dihydrate
D020011 - Protective Agents > D000975 - Antioxidants D018977 - Micronutrients > D014815 - Vitamins
(2S,3S)-2,3-BIS((4-CHLOROBENZOYL)OXY)SUCCINIC ACID
(r)-5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1h-indole
(CBZ-HYDRAZIDO)GLYCINETRIFLUOROACETATESALT
C14H5ClF10Si (425.9689359999999)
benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate
dipotassium [[N,N-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N,O,O,ON,ON]manganate(2-)
C10H16K2MgN2O10 (425.99295759999995)
Afuresertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively[1][2].
3-Deoxy 3-amino adenosine-5-diphosphate
C10H16N6O9P2 (426.04539859999994)
1-(Thiophen-2-ylmethyl)-3-thiophen-2-ylsulfonyl-2-pyrrolo[3,2-b]quinoxalinamine
3-O-methylfluorescein 6-phosphate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
4-Bromo-2-[3-(2-methoxyphenyl)acryloyl]phenyl 2-furoate
2-[[3-(3-Oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acid
(2S)-2-{[Hydroxy(4-iodobenzyl)phosphoryl]methyl}pentanedioic acid
5-(2,3-Dichlorophenyl)-N-(Pyridin-4-Ylmethyl)-3-Thiocyanatopyrazolo[1,5-A]pyrimidin-7-Amine
Mefoxin
C16H16N3O7S2- (426.04296459999995)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002513 - Cephamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
8-chloro-4-(3-chloro-4-fluoroanilino)-6-(1H-imidazol-5-ylmethylamino)-3-quinolinecarbonitrile
5-Chloropyridin-3-yl 1-[(4-methylphenyl)sulfonyl]-1h-indole-5-carboxylate
C21H15ClN2O4S (426.04410200000007)
7-(4-Chloro-benzyloxy)-2-(3,4-dihydroxy-phenyl)-3,5-dihydroxy-chromen-4-one
7-(3-Chloro-benzyloxy)-2-(3,4-dihydroxy-phenyl)-3,5-dihydroxy-chromen-4-one
N-(6-chloro-1,3-benzothiazol-2-yl)-2-diphenylphosphorylacetamide
C21H16ClN2O2PS (426.03585960000004)
Benzoic acid 4-bromo-2-[(5-methyl-2H-pyrazole-3-carbonyl)-hydrazonomethyl]-phenyl ester
2-[5-[(4-Bromophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-5-methyl-3-phenyl-4-isoxazolecarboxamide
2-[[2,2,2-trichloro-1-[(2,2-dimethyl-1-oxopropyl)amino]ethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid methyl ester
C16H21Cl3N2O3S (426.0338406000001)
5-(4-chlorophenyl)-3-{[(1E)-(2-hydroxy-3-nitrophenyl)methylene]amino}thieno[2,3-d]pyrimidin-4(3H)-one
C19H11ClN4O4S (426.01895160000004)
3-chloro-N-(2-furanylmethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide
ethyl 2-[[2,2,2-trichloro-1-(2-methylpropanoylamino)ethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
C16H21Cl3N2O3S (426.0338406000001)
(5-Hydroxy-11-methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraen-4-yl) hydrogen sulate
C17H14O11S (426.02568140000005)
cefoxitin(1-)
C16H16N3O7S2 (426.04296459999995)
A cephalosporin carboxylic acid anion having methoxy, 2-thienylacetamido and carbamoyloxymethyl side-groups, formed by proton loss from the carboxy group of the semisynthetic cephamycin antibiotic cefoxitin.
[5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6-methoxy-4-oxochromen-3-yl]oxidanesulfonic acid
C17H14O11S (426.02568140000005)
(3s)-3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one
C21H14O10 (426.05869440000004)
methyl 5,13-dichloro-15-formyl-6,14-dihydroxy-7,12-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-4-carboxylate
6,7,14-trihydroxy-13-(2,3,4-trihydroxyphenoxy)-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione
methyl (4z,6r,7s)-14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoate
C15H24Br2O4 (426.00412239999997)
methyl 14,14-dibromo-6,7-dihydroxytetradeca-4,13-dienoate
C15H24Br2O4 (426.00412239999997)
3-(3,4-dihydroxyphenyl)-8,10-dihydroxy-5-(2,4,6-trihydroxyphenyl)-2,4-dioxatricyclo[5.4.0.0³,⁵]undeca-1(11),7,9-trien-6-one
C21H14O10 (426.05869440000004)